Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Dimension Management, L.P. reported a 7.70% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G)
Event May 16, 2024 · Filed Oct 3, 2025
Dimension Management, L.P. reported a 7.70% stake in Monte Rosa Therapeutics, Inc., 4,757,563 shares, as a passive investor on May 16, 2024. Filed Oct 3, 2025 (Schedule 13G).
- Stake
- 7.70%
- Shares
- 4,757,563
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adam Goulburn | 7.70% | 4,757,563 |
| Zavain Dar | 7.70% | 4,757,563 |
| Nan Li | 7.70% | 4,757,563 |
| Dimension Management, L.P. | 7.70% | 4,757,563 |
| Dimension Capital I GP, LLC | 7.70% | 4,757,563 |
| Dimension Management GP, LLC | 7.70% | 4,757,563 |
| Dimension Capital I, L.P. | 7.70% | 4,757,563 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Dimension Management, L.P.
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G/A · Dimension Management, L.P. · Apr 22, 2026
- Schedule 13G/A · Dimension Management, L.P. · Jan 21, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026